Mesenchymal Stem (Stromal) Cells for Treatment of ARDS: A Phase 1 Clinical Trial

BACKGROUND: There is no effective pharmacotherapy for the acute respiratory distress syndrome (ARDS), and mortality remains high. Preclinical studies support the efficacy of mesenchymal stem (stromal) cells (MSCs) in the treatment of lung injury. The aim of this phase one clinical trial was to test...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Izdano u:Lancet Respir Med
Glavni autori: Wilson, Jennifer G., Liu, Kathleen D., Zhuo, Hanjing, Caballero, Lizette, McMillan, Melanie, Fang, Xiaohui, Cosgrove, Katherine, Vojnik, Rosemary, Calfee, Carolyn S., Lee, Jae-Woo, Rogers, Angela J., Levitt, Joseph, Wiener-Kronish, Jeanine, Bajwa, Ednan K., Leavitt, Andrew, McKenna, David, Thompson, B. Taylor, Matthay, Michael A.
Format: Artigo
Jezik:Inglês
Izdano: 2014
Teme:
Article
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC4297579/
https://ncbi.nlm.nih.gov/pubmed/25529339
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/S2213-2600(14)70291-7
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items